BioDuro

BioDuro appoints Greg Makara as senior VP

HTP Desk - 0
drug

Experts flag rising threat of drug-resistant superbugs 

HTP Desk - 0
health

Second World Summit on Sustainable Health and Well-Being 2026

HTP Desk - 0
CEVIRA (APL-1702) is a photodynamic drug-device combination product being developed for the non-surgical treatment of cervical precancerous lesions associated with HPV.

Asieris Pharmaceuticals’ licensing agreement with Theramex for Cevira

HTP Desk - 1
Medica

Medica brings digital innovations closer to everyday clinical practice

HTP Desk - 0
Alcami

Alcami strengthens commercial operations 

HTP Desk - 0
Orexo

Orexo resubmits new drug application for Izipry to USFDA

HTP Desk - 0
Bone

Bone fractures a concern for elderly, especially women

HTP Desk - 0
Gerresheimer

Gerresheimer reports Q2 2026

HTP Desk - 0
Sun

LIB Therapeutics and Sun Pharma deal to sell Lerodalcibep

HTP Desk - 0
Load more